https://doi.org/10.5812/jjm.65359

Identification of Candida Species Isolated from Vulvovaginal Candidiasis Patients by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) in Yasuj Southwestern Iran

authors:

avatar Maral Gharaghani ORCID 1 , avatar Bahram Ahmadi ORCID 2 , avatar Marzie Taheripour Sisakht 3 , avatar Owrange Ilami ORCID 4 , avatar Shahintaj Aramesh 5 , avatar Fariba Mouhamadi 5 , avatar Zohreh Barati 5 , avatar Shohreh Roozmeh 6 , avatar Haniyeh Mohammadi 3 , avatar Sadegh Nouripour-Sisakht 4 , *

Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Department of Microbiology and Parasitology, School of Para-Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
Department of Obstetrics and Gynecology, Yasuj University of Medical Sciences, Yasuj, Iran
Department of Obstetrics and Gynecology, Shiraz University of Medical Sciences, Shiraz, Iran
Jundishapur Journal of Microbiology: Vol.11, issue 8; e65359
published online: July 28, 2018
article type: Research Article
received: December 20, 2017
revised: July 15, 2018
accepted: July 16, 2018

how to cite: Gharaghani M, Ahmadi B, Taheripour Sisakht M, Ilami O , Aramesh S, et al. Identification of Candida Species Isolated from Vulvovaginal Candidiasis Patients by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) in Yasuj Southwestern Iran. Jundishapur J Microbiol. 2018;11(8):e65359. https://doi.org/10.5812/jjm.65359.

Abstract

Background:

Vulvovaginal candidiasis (VVC) is a frequent infection in females at the reproductive age. Furthermore, the most common causative agent is Candida albicans yet in the recent years, the incidence of non-albicans species has increased.

Objectives:

The main aim of this study was the isolation and identification of various Candida species from patients with vulvovaginal candidiasis by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in Yasuj, Iran.

Methods:

Three hundred and ten suspected women females vaginitis were sampled and examined. Genomic DNA was extracted from fresh colonies by phenol-chloroform glass bead methods. Polymerase chain reaction (PCR) amplification was performed based on the ribosomal DNA internal transcribed spacer (rDNA-ITS), and specific electrophoretic patterns of PCR products after digestion with MspI enzyme used for species identification.

Results:

The cultures were positive for 160 (51.6%) vaginal samples. Candida albicans (86.8%) was the most common species among the isolates, followed by C. glabrata (3.77%) and C. krusei (3%). Multispecies with two Candida were identified in nine patients.

Conclusions:

Vulvovaginal candidiasis is more prevalent among females in Yasuj and the predominant agent is C. albicans. In addition, correct identification of Candida species could play an important role in management and treatment of VVC.

1. Background

Vulvovaginal candidiasis (VVC) is an usual infection among females, which occurs due to different species of Candida (1). Candida is the second most common cause of vaginal infection after bacterial vaginitis (2). Many reports have suggested that the majority of sexually active females will experience at least one symptomatic vaginal candidiasis during their life; 40% to 50% of these females will experience a second episode and 5% to 10% develop the recurrent form, characterized by three or more episodes in a year (2, 3). Predisposing factors for VVC may include pregnancy, antimicrobial therapy, uncontrolled diabetic mellitus, using of high-estrogen oral contraceptives and hormone drug replacement therapy, use of corticosteroids, cancer chemotherapy, organ transplantation, tight fitting closing, increase in sexual activity, and vaginal douching (4). Symptomatic VVC is characterized by vulvar pruritus, burning, sureness, abnormal vaginal discharge, irritation, and dyspareunia (5, 6). Differential diagnosis of vulvovaginal candidiasis from bacterial vaginitis and trichomoniasis is difficult based on signs and symptoms and leads to suboptimal care (7).

Vulvovaginal candidiasis is most commonly caused by Candida albicans yet in the recent years the rate of infection by non-albicans species, such as C. glabrata, has increased (5, 8). In addition, the correct identification and differentiation of etiological agents is very important for early treatment and preventing of invasion (9). For a long time, traditional microbiological procedures, such as morphology and biochemical methods, were used to identify Candida species, yet these methods are time-consuming, inaccurate to identify, and lacking the necessary validity (10-12). Several DNA-based method, have been developed to improve the identification of fungi species (10, 13). The ITS regions of rDNA contains highly variable nucleotide sequences that have been used for identification of Candida species in the PCR assay. The advantages of PCR-RFLP method for differentiation of Candida species in clinical samples is simple, easy-to-perform, cost-effective, and rapid (11).

2. Objectives

The objective of the current study was to identify and determine various species of Candida isolates from females with VVC, using PCR-RFLP for elucidation of epidemiological aspects of vulvovaginal candidiasis.

3. Methods

3.1. Ethics Statement

The ethics committee of the Yasuj University of Medical Sciences approved this study with ethical no.IR.YUMS.REC.1395.29.

3.2. Clinical Samples

This descriptive study was conducted over a period of one year (2016 to 2107) on vaginal samples of patients clinically suspected and diagnosed with VVC that had referred to gynecology and (obstetrics) private midwifery clinics (Yasuj, Iran). The inclusion criteria included living in Yasuj city, being in the menstrual phase, and having an active sexual life while females with pregnancy, and local or systemic treatment for vaginitis were excluded from the study. The samples were collected by sterile cotton swabs from the lateral wall of patients’ vagina and cultured on Sabouraud dextrose agar (Merck, Germany) plates supplemented with 50 mg/L chloramphenicol to avoid bacterial growth and incubated at 35°C for two days. To ensure purity of the isolates, all yeasts were plated on CHROMagar Candida medium (CHROMagar™, Rambach™, AquaCHROM™).

3.3. Molecular Identification

For precise species identification, the extraction and purification of genomic DNA was done from colonies by using previously described methods by Mirhendi et al. (11). Briefly, a loop full of fresh colonies was added to in a 1.5-mL micro tube, containing 300 µL of phenol-chloroform (1:1) solution, 300 μL of lysis buffer (10 mM Tris, 1% SDS, 1 mM EDTA (pH 8), 100 mM NaCl, 2% Triton X-100), and equal to 300 µL of glass beads (0.5 mm in diameter). The suspension was vortexed vigorously for five minutes, centrifuged at 10000 rpm for five minutes, and then the supernatant was transferred to a new tube and re-extracted once more with chloroform. The nucleic acid was precipitated with 2.5 mL volume of cold absolute ethanol and 0.1 mL volume of sodium acetate (pH 5.2) centrifuged at 10000 rpm for 10 minutes at 4°C and the pellets were washed with 300 mL of 70% ethanol, air dried, and finally the pellets rehydrated in 100 µL TE buffer (10 mM Tris, 1 mM EDTA) and were stored at -20°C until use for PCR amplification.

3.4. Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR- RFLP)

The PCR-RFLP method was carried out according to an already available method, previously described by Mirhendi et al. (11). Briefly, 0.2 µM of each forward ITS1 (5’-TCC GTAGGT GAA CCT GCG G-3’) and reverse ITS4 (5’-TCC TCC GCT TAT TGA TAT GC-3’) universal primers, 1 µL of template DNA, 12.5 µL of premix (Amplicon, Denmark), and enough deionized distilled water up to a final volume of a 25 µL were used for PCR amplification of the ITS1-5.8S-ITS2 rDNA region by thermal conditions according to the following scheme: Initial denaturation during five minutes at 94°C, 35 cycles of amplification consisting of denaturation for 30 seconds at 94°C, annealing for 30 seconds at 58°C and extension for on minutes at 72°C, followed by final extension step at 72°C for seven minutes. To achieve precise strain discriminatory patterns, PCR products were digested in a final reaction volume of 15 µL containing a 10 µL of PCR product, 1U of restriction enzyme MspI (Fermentas, Vilnius, Lithuania), 1.5 µL of relevant buffer, and 3 µL of deionized distilled water at 37°C for two hours. Amplified and digested products were analyzed by agarose gel electrophoresis in TBE buffer (Tris 0.09 M, EDTA 2mM, Boric acid 0.09 M) containing 0.5 µ/mL of ethidium bromide, at 100 V for approximately one hour using 1.5% and 2% agarose gels, respectively. For species identification, the size of the digested fragment was compared with reference band profiles (13).

4. Results

Overall, 310 females suspected of vulvovaginal candidiasis were examined in the present study. The mean age of the patients was 31 with a range of 19 to 53 years. Itching, irritation, discharge, dyspareunia, and erythema were found in 80% of patient. In the present study, 160 (51.6%) patients of 310 suspected females were positive for vulvovaginal candidiasis. The culture results show that C. albicans was the predominant species 139/160 (86.8%), followed by C. glabrata 6/160 (3.77%), C. krusei 5/160 (3.1%), mixed infection of C. albicans and C. glabrata 7/160 (4.37%), C. albicans and C. krusei 2/160(1.3%), and C. kefyr 1/160 (0.65%). The overall prevalence of none-albicans Candida species in the study was 13.2%. Vaginal samples 151/160 (94.35%) contained only one species of Candida and 9/160 (5.62%) more than one species of Candida. Non-albicans species were more commonly isolated from the culture of patients with mixed infection. Figure 1 shows the PCR-RFLP results for identification of isolated Candida species.

Agarose gel electrophoresis of restriction fragments length polymorphism ITS gene from Candida species isolated from vulvovaginal candidiasis with Candida albicans (lanes 1 - 4), C. glabrata (lanes 5 - 6), C. krusei (lanes 7 - 9), C. kefyr (lane 10), and Lane M represents a 100 bp size molecular marker.
Agarose gel electrophoresis of restriction fragments length polymorphism ITS gene from Candida species isolated from vulvovaginal candidiasis with Candida albicans (lanes 1 - 4), C. glabrata (lanes 5 - 6), C. krusei (lanes 7 - 9), C. kefyr (lane 10), and Lane M represents a 100 bp size molecular marker.
Figure 1.

Agarose gel electrophoresis of restriction fragments length polymorphism ITS gene from Candida species isolated from vulvovaginal candidiasis with Candida albicans (lanes 1 - 4), C. glabrata (lanes 5 - 6), C. krusei (lanes 7 - 9), C. kefyr (lane 10), and Lane M represents a 100 bp size molecular marker.

5. Discussion

Vulvovaginal candidiasis results from increasing growth of Candida species in the mucous of genital tract and has enlarged extremely in the recent years (14). The PCR-RFLP was used to identify yeast isolated from patients with VVC. The frequency of VVC varied from 5.4% to 84% in reports from Iran and abroad (3, 7, 9, 15, 16). The findings revealed that the prevalence of Candida vaginitis was 160 (51.6%). These results are similar to Mohamadi et al. (17), Hedayati et al. (15), and Rasti et al.’s studies (18). Furthermore, the present study indicated the high rate of VVC in 30- to 40-year-olds, which is in agreement with the study of Mohamadi et al. (17), while it is in contrast with Rezaei-Matekolaei et al. (19).

The current results showed the high prevalence of C. albicans in VVC. This finding was in concordance with the studies of Roshan et al. (86.2%) (9), Roudbary et al. (82.2%) (16), Rezaei-Matehkolaei et al. (88.2%) (19), Mahmoudi Rad (65.1%) (20), and Fan et al. (89.5%) (21). On the other hand, during the last decade, the frequency of non-albicans species has increased. The current study documented a prevalence of 13.9% for non-albicans species, while this is in contrast to other studies, for example Lakshmi (7) reported a striking increase of non-albicans Candida species with a prevalence of 59.2% from all Candida species. Also, Richter et al. (22) reported that 24% of 593 symptomatic patients were non-albicans species in 1998 to 2001. Hedayati et al., using CHROM Candida agar medium for identification of two major Candida species and Hicandida kit for final differentiation of Candida species, showed non-albicans isolates of Candida, such as C. glabrata, C. dubliniensis, C. kefyr, and C. pintolopesii were more frequent than C. albicans (57.5% versus 42.5%) (15). However, non-albicans Candida species may cause more severe symptoms and are often more difficult to treat (22, 23). The second most common isolated species in this study was C. glabrata, which was in agreement with similar studies (9, 16) yet Lakshmi and Budhani reported C. tropicalis as the common non-albicans species (7, 14, 24).

The prevalence of C. glabrata in this study was 7%, however, this is in contrast to other reported Abu-Elteen and Lakshmi by CHROMagar Candida and conventional mycological methods that reported 32.5% and 11.11% prevalence for C. glabrata, respectively (25). Also, Trama et al. reported a higher rate of C. glabrata species than the current study: 14.3% of 1316 isolates in vulvovaginitis (6). As well as, a report from India indicated that C. glabrata was major agent (50.4%) in VVC (25). The third Candida agent of VVC in the current study was C. krusei (3.1%); the current results are similar to a study conducted by Mahmoudi Rad et al. (20), which reported the rate of C. krusei (4%). Candida kefyr is a rare and unusual cause of VVC as previously reported by Hedayati et al. (8.2%) (15), Rezaei-Matehkolaei et al. (2.9%) (19), and Fornari et al. (2.5%) (26). However, C. kefyr was isolated from only one patient in the current study; the rate of C. kefyr isolation in the present study was 0.65%, which is lower than previous studies mentioned above. The results of this study showed that 5.63% of participants were infected with more than one species of Candida. This finding is in agreement with Mahmoudi Rad et al.’s, which reported the prevalence of mix infection as 10% (20).

5.1. Conclusions

Vulvovaginal candidiasis is more prevalent among females in Yasuj and the predominant agent is C. albicans. According to the point that excessive use of antifungal drugs without prescription for treatment of vaginal infection can lead to induction of Candida resistance, correct identification of Candida species could play an important role in treatment of VVC.

Acknowledgements

References

  • 1.

    Monroy-Perez E, Paniagua-Contreras GL, Rodriguez-Purata P, Vaca-Paniagua F, Vazquez-Villasenor M, Diaz-Velasquez C, et al. High Virulence and Antifungal Resistance in Clinical Strains of Candida albicans. Can J Infect Dis Med Microbiol. 2016;2016:5930489. [PubMed ID: 28058052]. [PubMed Central ID: PMC5183749]. https://doi.org/10.1155/2016/5930489.

  • 2.

    Sobel JD. Genital Candidiasis. Sexually Transmitted Infections and Sexually Transmitted Diseases. Springer; 2011. p. 613-24. https://doi.org/10.1007/978-3-642-14663-3_46.

  • 3.

    Lopes PHS, Pacini VL, Norberg AN. Genital infection by gardnerella vaginalis and candida spp. Among women in Nova Iguacu city, Rio de Janeiro Province, Brazil. Open Access Libr J. 2017;4(3):1-7. https://doi.org/10.4236/oalib.1103366.

  • 4.

    Apalata T, Longo-Mbenza B, Sturm A, Carr W, Moodley P. Factors Associated with Symptomatic Vulvovaginal Candidiasis: A Study among Women Attending a Primary Healthcare Clinic in Kwazulu-Natal, South Africa. Ann Med Health Sci Res. 2014;4(3):410-6. [PubMed ID: 24971218]. [PubMed Central ID: PMC4071743]. https://doi.org/10.4103/2141-9248.133470.

  • 5.

    Carlson P, Richardson M, Paavonen J. Evaluation of the Oricult-N dipslide for laboratory diagnosis of vaginal candidiasis. J Clin Microbiol. 2000;38(3):1063-5. [PubMed ID: 10698997]. [PubMed Central ID: PMC86339].

  • 6.

    Trama JP, Adelson ME, Raphaelli I, Stemmer SM, Mordechai E. Detection of Candida species in vaginal samples in a clinical laboratory setting. Infect Dis Obstet Gynecol. 2005;13(2):63-7. [PubMed ID: 16011995]. [PubMed Central ID: PMC1784561]. https://doi.org/10.1080/10647440400025629.

  • 7.

    Lakshmi PM. Isolation and speciation of candida from vaginitis cases attending gynaecology OPD in a tertiary care hospital A.P. India. Int J Curr Microbiol App Sci. 2016;5(10):229-32. https://doi.org/10.20546/ijcmas.2016.510.024.

  • 8.

    Boatto HF, Cavalcanti SD, Del Negro GM, Girao MJ, Francisco EC, Ishida K, et al. Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil. Mem Inst Oswaldo Cruz. 2016;111(6):407-10. [PubMed ID: 27304096]. [PubMed Central ID: PMC4909041]. https://doi.org/10.1590/0074-02760160166.

  • 9.

    Roshan R, Sabokbar A, Badali H. Identification of Candida species isolated from vulvovaginal candidiasis using PCR-RFLP. Int J Mol Clin Microbiol. 2014;4(2):406-10.

  • 10.

    Criseo G, Scordino F, Romeo O. Current methods for identifying clinically important cryptic Candida species. J Microbiol Methods. 2015;111:50-6. [PubMed ID: 25659326]. https://doi.org/10.1016/j.mimet.2015.02.004.

  • 11.

    Mirhendi H, Makimura K, Khoramizadeh M, Yamaguchi H. A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Nihon Ishinkin Gakkai Zasshi. 2006;47(3):225-9. [PubMed ID: 16940958]. https://doi.org/10.3314/jjmm.47.225.

  • 12.

    Liguori G, Lucariello A, Colella G, De Luca A, Marinelli P. Rapid identification of Candida species in oral rinse solutions by PCR. J Clin Pathol. 2007;60(9):1035-9. [PubMed ID: 17761740]. [PubMed Central ID: PMC1972426]. https://doi.org/10.1136/jcp.2006.040782.

  • 13.

    Luo G, Mitchell TG. Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol. 2002;40(8):2860-5. [PubMed ID: 12149343]. [PubMed Central ID: PMC120665]. https://doi.org/10.1128/JCM.40.8.2860-2865.2002.

  • 14.

    Mohammadi R, Mirhendi H, Rezaei-Matehkolaei A, Ghahri M, Shidfar MR, Jalalizand N, et al. Molecular identification and distribution profile of Candida species isolated from Iranian patients. Med Mycol. 2013;51(6):657-63. [PubMed ID: 23470036]. https://doi.org/10.3109/13693786.2013.770603.

  • 15.

    Hedayati MT, Taheri Z, Galinimoghadam T, Aghili SR, Yazdani Cherati J, Mosayebi E. Isolation of different species of Candida in patients with vulvovaginal candidiasis from Sari, Iran. Jundishapur J Microbiol. 2015;8(4). e15992. [PubMed ID: 26034533]. [PubMed Central ID: PMC4449843]. https://doi.org/10.5812/jjm.8(4)2015.15992.

  • 16.

    Roudbary M, Roudbarmohammadi S, Bakhshi B, Farhadi Z, Nikoomanesh F. Identification of Candida species isolated from Iranian women with vaginal candidiasis by PCR-RFLP method. Eur J Exp Biol. 2013;3(6):365-9.

  • 17.

    Mohamadi J, Havasian MR, Panahi J, Pakzad I. Antifungal drug resistance pattern of Candida. spp isolated from vaginitis in Ilam-Iran during 2013-2014. Bioinformation. 2015;11(4):203-6. [PubMed ID: 26124561]. [PubMed Central ID: PMC4479047]. https://doi.org/10.6026/97320630011203.

  • 18.

    Rasti S, Asadi MA, Taghriri A, Behrashi M, Mousavie G. Vaginal candidiasis complications on pregnant women. Jundishapur J Microbiol. 2014;7(2). e10078. [PubMed ID: 25147665]. [PubMed Central ID: PMC4138689]. https://doi.org/10.5812/jjm.10078.

  • 19.

    Rezaei-Matehkolaei A, Shafiei S, Zarei-Mahmoudabadi A. Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species. Iran J Microbiol. 2016;8(6):410-7. [PubMed ID: 28491253]. [PubMed Central ID: PMC5420397].

  • 20.

    Mahmoudi Rad M, Zafarghandi A, Amel Zabihi M, Tavallaee M, Mirdamadi Y. Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR. Infect Dis Obstet Gynecol. 2012;2012:872169. [PubMed ID: 22791958]. [PubMed Central ID: PMC3389677]. https://doi.org/10.1155/2012/872169.

  • 21.

    Fan SR, Liu XP, Li JW. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. J Obstet Gynaecol Res. 2008;34(4):561-6. [PubMed ID: 18937710]. https://doi.org/10.1111/j.1447-0756.2008.00817.x.

  • 22.

    Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43(5):2155-62. [PubMed ID: 15872235]. [PubMed Central ID: PMC1153777]. https://doi.org/10.1128/JCM.43.5.2155-2162.2005.

  • 23.

    Mintz JD, Martens MG. Prevalence of non-albicans candida infections in women with recurrent vulvovaginal symptomatology. Adv Infect Dis. 2013;3(4):238-42. https://doi.org/10.4236/aid.2013.34035.

  • 24.

    Budhani D, Mehta S, Rudra S, Kumar A. Isolation, Identificatison and anti-fungal susceptibility of candida species from clinically suspected cases of vulvovaginitis in a tertiary care hospital in rural area - a cross-sectional study. India J Microbiol Res. 2016;3(2):122-5. https://doi.org/10.5958/2394-5478.2016.00029.7.

  • 25.

    Abu-Elteen KH. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan. Jpn J Infect Dis. 2001;54(3):103-7. [PubMed ID: 11544399].

  • 26.

    Fornari G, Vicente VA, Gomes RR, Muro MD, Pinheiro RL, Ferrari C, et al. Susceptibility and molecular characterization of Candida species from patients with vulvovaginitis. Braz J Microbiol. 2016;47(2):373-80. [PubMed ID: 26991298]. [PubMed Central ID: PMC4874609]. https://doi.org/10.1016/j.bjm.2016.01.005.